Manufacturing companies are increasingly expected to demonstrate measurable environmental improvements rather than simply publish sustainability commitments. INTCO Medical’s 2025 Environmental, Social and Governance (ESG) Report reflects that shift, presenting operational metrics across emissions, renewable energy, manufacturing efficiency, governance, and supply chain management as investors and customers place greater emphasis on quantifiable performance.
The global manufacturer of disposable gloves reported that carbon emissions per glove declined to 18.14 grams of carbon dioxide equivalent in 2025, representing an 11.14% reduction from the previous year and a 32.5% decrease compared with its 2022 baseline. The result exceeds the company’s interim objective of reducing emissions intensity by 25% before 2030, suggesting operational improvements have progressed faster than initially planned.
The report attributes the reduction primarily to manufacturing efficiency gains and increased renewable electricity generation. During 2025, INTCO Medical produced 12,537.23 MWh of electricity from solar and wind installations at its manufacturing facilities, supporting broader efforts to lower the carbon intensity of production. The company continues to target carbon neutrality across its own operations by 2050.
Water efficiency also improved during the reporting period. Water consumption per glove declined to 0.20 liters, a 6.88% year over year reduction that met the company’s previously established 2024 efficiency target. For manufacturers operating in water intensive industrial processes, improving resource productivity has become increasingly important as environmental regulations tighten and operating costs rise.
The company’s sustainability strategy extends beyond environmental performance to manufacturing modernization. According to the report, INTCO Medical continued investing in research and development, automated production lines, digital manufacturing systems, and precision process controls designed to improve production efficiency while maintaining product quality. These investments support the company’s three primary business segments comprising medical consumables, rehabilitation medical equipment, and physical therapy products.
Digitalization has become an increasingly important component of industrial sustainability strategies because automation and process optimization can simultaneously improve resource utilization, reduce waste, and enhance production consistency. For medical product manufacturers, maintaining internationally recognized quality standards while improving manufacturing efficiency remains critical given stringent regulatory requirements across major export markets.
INTCO Medical stated that it continues to operate under internationally recognized quality management frameworks, including ISO 13485 for medical devices and ISO 9001 quality management standards. The company supplies customers across more than 150 countries and regions, making compliance with multiple regulatory systems an important competitive requirement.
Supply chain governance also remains a central element of ESG reporting as manufacturers face growing scrutiny over sourcing practices and supplier performance. The report indicates that sustainability considerations are incorporated into supplier evaluation and management processes alongside broader efforts to strengthen transparency and operational reliability throughout the company’s value chain.
Social performance metrics published in the report include a workforce of 12,941 employees at the end of 2025. Women represented 57.76% of total employees, 35% of management positions, and 55.56% of board members. Employee training reached full workforce coverage during the year, averaging 31.55 hours per employee.
Beyond operational activities, the company reported cumulative charitable contributions exceeding RMB 76.86 million by year end, supporting initiatives related to healthcare, education, disability assistance, and community development.
External ESG assessments continue to play an increasingly important role in corporate reporting as investors seek standardized benchmarks across industries. During 2025, INTCO Medical received an A rating from Wind ESG, earned EcoVadis’ “Committed” badge for the second consecutive year, maintained WRAP and BSCI certifications, and obtained life cycle assessment and carbon footprint certifications for its products. The company was also included in S&P Global’s Sustainability Yearbook (China Edition) 2025 as a Best Improvement Company and recognized in Bloomberg Businessweek/Green Gold’s 2026 ESG Leaders to Watch list.
